Acrivon Therapeutics (ACRV) vs Citius Oncology (CTOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Acrivon Therapeutics (ACRV) has outperformed Citius Oncology (CTOR) over the past year, losing 1.6% versus a loss of 54.7%. Citius Oncology is the larger company by market cap ($88.3 million vs $80.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACRV | CTOR |
|---|---|---|
| Share price | $1.87 | $0.835 |
| Market cap | $80.14M | $88.31M |
| 1-day change | -0.53% | -2.45% |
| YTD return | -21.99% | -14.90% |
| 1-year return | -1.57% | -54.73% |
| EPS (TTM) | $-1.88 | $-0.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.56 | $2.25 |
| 52-week low | $1.27 | $0.491 |
| Distance from 52-week high | -47.47% | -62.89% |
| Average volume | 361.40K | 99.72K |
| Shares outstanding | 42.85M | 105.76M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACRV has outperformed CTOR by 53.2 percentage points over the past year.
ACRV vs CTOR FAQ
Which is bigger, Acrivon Therapeutics or Citius Oncology?
Citius Oncology (CTOR) is larger, with a market capitalization of $88.31M compared with $80.14M for Acrivon Therapeutics (ACRV).
Which stock has performed better over the past year, ACRV or CTOR?
ACRV returned -1.57% over the past 12 months, compared with -54.73% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Acrivon Therapeutics and Citius Oncology in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.